| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/22/1996 | CA2197446A1 Antigenically-marked non-infectious retrovirus-like particles |
| 02/22/1996 | CA2197232A1 Method of producing single-chain fv molecules |
| 02/22/1996 | CA2196594A1 Use of antibodies to cck to improve feed efficiency |
| 02/22/1996 | CA2196415A1 Peroral immunogen composition and process for producing the same |
| 02/22/1996 | CA2196208A1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
| 02/21/1996 | EP0697024A1 Downregulation of allergen-specific immune response |
| 02/21/1996 | EP0697023A1 3-(aminoacyl-amino)-saccharides and method for preparing them |
| 02/21/1996 | EP0516785B1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF alpha |
| 02/21/1996 | CN1031039C Swine dysentery vaccine |
| 02/20/1996 | US5492890 Polypeptides for promoting cell attachment |
| 02/20/1996 | US5492695 Vaccinating cats against Dirofilaria immitis with an L4 homogenate |
| 02/20/1996 | US5492694 Fusobacterium leukotoxoid vaccine |
| 02/20/1996 | US5492314 Preloaded digressive rate mount |
| 02/20/1996 | CA1338079C Adhesion protein micelles |
| 02/20/1996 | CA1338078C Partial cationization of protein-containing antigens and method of immunization and desensitization |
| 02/20/1996 | CA1338069C Bovine herpesvirus type 1 polypeptides and vaccines |
| 02/15/1996 | WO1996004394A1 Hsv viral vector |
| 02/15/1996 | WO1996004388A1 Novel compounds |
| 02/15/1996 | WO1996004385A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 02/15/1996 | WO1996004384A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 02/15/1996 | WO1996004383A1 Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
| 02/15/1996 | WO1996004382A2 Secreted viral proteins useful for vaccines and diagnostics |
| 02/15/1996 | WO1996004380A1 D2d3 polypeptide from staphylococcus aureus and uses thereof |
| 02/15/1996 | WO1996004379A1 Methods and compositions for the expression of a bone and prostate derived growth factor |
| 02/15/1996 | WO1996004378A2 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
| 02/15/1996 | WO1996004376A1 Hepatitis a virus receptor and methods of use |
| 02/15/1996 | WO1996004314A1 Mhc complexes and uses thereof |
| 02/15/1996 | WO1996004313A1 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 02/15/1996 | WO1996004310A1 Contraceptive vaccine |
| 02/15/1996 | WO1996004302A1 Novel tumor marker for lung cancer |
| 02/15/1996 | WO1996004301A2 Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same |
| 02/15/1996 | WO1996004015A1 Microparticle preparations for clearing blood-dissolved substances |
| 02/15/1996 | WO1996004011A2 Novel compound to mimic a naturally occurring peptide's effect |
| 02/15/1996 | WO1996004010A1 Vr-2332 viral nucleotide sequence and methods of use |
| 02/15/1996 | WO1996004009A1 Anti-aids secretory recombinant bcg vaccine |
| 02/15/1996 | WO1996004003A1 Use of fibronectin binding proteins in oral hygiene |
| 02/15/1996 | WO1996003984A1 Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| 02/15/1996 | WO1996000083A3 Method of isolating an antigene preparation |
| 02/15/1996 | WO1995026982A3 Malaria peptides |
| 02/15/1996 | CA2328638A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 02/15/1996 | CA2196290A1 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
| 02/15/1996 | CA2196285A1 Contraceptive vaccine |
| 02/15/1996 | CA2196200A1 Novel compounds |
| 02/15/1996 | CA2195965A1 Hsv viral vector |
| 02/15/1996 | CA2195312A1 Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same |
| 02/15/1996 | CA2172273A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 02/14/1996 | EP0696640A2 Recombinant antigen from the NS3 region of hepatitis C virus |
| 02/14/1996 | EP0696596A1 Detection, assay and isolation of compounds having the taxane ring skeleton |
| 02/14/1996 | EP0696456A2 Combination of necrosis inducing substances with substances which are activated by necrosis for the selective treatment of tumours and or inflammatory diseases |
| 02/14/1996 | EP0696326A1 Methods of treating and detecting cancer using viruses |
| 02/14/1996 | EP0696322A1 METHODS AND COMPOSITIONS FOR $i(SALMONELLA)-BASED VACCINES |
| 02/14/1996 | EP0696318A1 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies |
| 02/14/1996 | EP0696290A1 Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation |
| 02/14/1996 | EP0696270A1 4-amino-fluorobenzamides and their use as cytotoxic prodrugs |
| 02/14/1996 | EP0696208A1 Oral drug delivery compositions and methods |
| 02/14/1996 | EP0696204A1 Recombinant fowlpox viruses and uses thereof |
| 02/14/1996 | EP0205579B1 Methods and compositions useful in the diagnosis and treatment of autoimmune diseases |
| 02/14/1996 | CN1116548A Polyclonal antibody, preparing process and use thereof |
| 02/13/1996 | US5491218 Immunochemical detection |
| 02/13/1996 | US5491088 Genetic engineering |
| 02/13/1996 | US5491073 Cloning of chicken anaemia DNA |
| 02/13/1996 | US5491065 Monoclonal antibodies that bind to and neutralize dimeric but not monomeric human M-CSF and methods of use thereof for detection of dimeric M-CSF |
| 02/13/1996 | US5490988 Delivery of therapeutic agents to a target site |
| 02/08/1996 | WO1996003510A1 A polynucleotide herpes virus vaccine |
| 02/08/1996 | WO1996003508A1 Dna encoding ovine adenovirus (oav287) and its use as a viral vector |
| 02/08/1996 | WO1996003507A1 Method of isolating attenuated virus and vaccine thereof |
| 02/08/1996 | WO1996003506A2 Analog of haemophilus hin47 with reduced protease activity |
| 02/08/1996 | WO1996003499A1 Receptor-ligand assay |
| 02/08/1996 | WO1996003438A1 Antibodies which activate an erythropoietin receptor |
| 02/08/1996 | WO1996003146A1 Retroviral transduction of cells using soluble complement inhibitors |
| 02/08/1996 | WO1996003145A1 Influenza virus subunit conjugates |
| 02/08/1996 | WO1996003144A1 Polyepitope vaccines |
| 02/08/1996 | WO1996003141A1 Pharmaceutical compositions comprising a chimaeric tnf binding protein |
| 02/08/1996 | WO1996003140A1 HLA binding peptides and their uses |
| 02/08/1996 | DE4428056A1 Verwendung von Mikropartikelpräparationen zur Eliminierung gelöster, nicht nierengängiger Substanzen aus dem Blut Use of microparticle preparations for eliminating the dissolved, non-renal common substances from the blood |
| 02/08/1996 | DE4192335C2 New T-cell epitope(s) derived from the TraT protein of E.Coli |
| 02/08/1996 | CA2195868A1 Antibodies which activate an erythropoietin receptor |
| 02/08/1996 | CA2195800A1 Receptor-ligand assay |
| 02/08/1996 | CA2195671A1 Hla binding peptides and their uses |
| 02/08/1996 | CA2195665A1 Pharmaceutical compositions comprising a chimaeric tnf binding protein |
| 02/08/1996 | CA2195642A1 Polyepitope vaccines |
| 02/08/1996 | CA2195539A1 Dna encoding ovine adenovirus (oav287) and its use as a viral vector |
| 02/08/1996 | CA2195099A1 A polynucleotide herpes virus vaccine |
| 02/08/1996 | CA2194973A1 Retroviral transduction of cells using soluble complement inhibitors |
| 02/08/1996 | CA2194183A1 Influenza virus subunit conjugates |
| 02/07/1996 | EP0695803A2 Epitopic regions of pneumococcal surface protein A |
| 02/07/1996 | EP0695760A1 Novel tumor marker for lung cancer |
| 02/07/1996 | EP0695360A1 Defective recombinant adenoviruses for gene therapy of tumours |
| 02/07/1996 | EP0695358A1 Recombinant antigens from mumps virus and their use in vaccines |
| 02/07/1996 | EP0695357A1 Mammal cell lines and method of obtaining glycoproteins |
| 02/07/1996 | EP0695356A1 Cloning, expression and vaccine composition corresponding to a peptide antigen of toxoplasma gondii |
| 02/07/1996 | EP0695347A1 Methods and materials for treatment of individuals infected with intracellular infectious agents |
| 02/07/1996 | EP0695312A1 Immunoparticles bearing monoclonal anti-cd4 antibodies and utilisation thereof |
| 02/07/1996 | EP0695194A1 Improved detection and therapy of lesions with biotin/avidin polymer conjugates |
| 02/07/1996 | EP0695192A1 Gonococcal anti-idiotypic antibodies and methods and compositions using them |
| 02/07/1996 | EP0695191A1 35/31 kDa SUBUNIT OF THE $i(ENTAMOEBA HISTOLYTICA) ADHERENCE LECTIN |
| 02/07/1996 | EP0695189A1 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 02/07/1996 | EP0420848B1 Carcinoma-associated antigens, and antibodies which recognize these antigens |
| 02/07/1996 | CN1116118A Double specific immunity lipide medicine and preparation thereof |
| 02/06/1996 | US5489533 Human intercellular adhesion molecule-2; antiinflammatory agents |